Optimizing bioconversion pathways through systems analysis and metabolic engineering

Proceedings of the National Academy of Sciences of the United States of America

Volumn 99, Issue 4, 2002, Pages 1801-1806

  Stafford, Daniel E ^a   Yanagimachi, Kurt S ^a   Lessard, Philip A ^b   Rijhwani, Sushil K ^a   Sinskey, Anthony J ^b   Stephanopoulos, Gregory ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 INDANDIOL; ALCOHOL DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INDINAVIR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BIOTRANSFORMATION; CATALYSIS; CHEMOSTAT; CONTROLLED STUDY; GENE OVEREXPRESSION; METABOLIC ENGINEERING; NONHUMAN; PARTIAL DRUG SYNTHESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RHODOCOCCUS; SYSTEM ANALYSIS; TECHNIQUE; VALIDATION PROCESS;

BIOMEDICAL ENGINEERING; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INDUSTRY; EPOXIDE HYDROLASES; FERMENTATION; GENETIC ENGINEERING; HYDROLYSIS; INDANS; INDENES; METABOLISM; MODELS, CHEMICAL; PLASMIDS; RHODOCOCCUS; SYSTEMS ANALYSIS; TIME FACTORS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; RHODOCOCCUS;

EID: 0037133330     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.032681699     Document Type: Article

References (20)